In conclusion, DNA methylation of CAFs, myeloid-derived suppressor cells, and CD8+ tumor-infiltrating lymphocytes can be applied to the clinical diagnosis, treatment, and prognosis of cancer with significant clinical implications. This evidence concerns the gene CD8A and neoplasm.